ALFAVISION S | WELCURE DRUG | ALFAVISION S/ WELCURE DRUG |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -14.6 | 598.2 | - | View Chart |
P/BV | x | 1.0 | 4.3 | 23.7% | View Chart |
Dividend Yield | % | 0.4 | 0.0 | - |
ALFAVISION S WELCURE DRUG |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ALFAVISION S Mar-23 |
WELCURE DRUG Mar-23 |
ALFAVISION S/ WELCURE DRUG |
5-Yr Chart Click to enlarge
|
||
High | Rs | 42 | 12 | 360.2% | |
Low | Rs | 10 | 4 | 276.7% | |
Sales per share (Unadj.) | Rs | 18.6 | 0 | - | |
Earnings per share (Unadj.) | Rs | -0.7 | 0.1 | -909.5% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 0.1 | -863.5% | |
Dividends per share (Unadj.) | Rs | 0.05 | 0 | - | |
Avg Dividend yield | % | 0.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 13.7 | 1.1 | 1,224.0% | |
Shares outstanding (eoy) | m | 31.53 | 13.51 | 233.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.4 | 0 | - | |
Avg P/E ratio | x | -37.6 | 100.7 | -37.3% | |
P/CF ratio (eoy) | x | -38.4 | 97.5 | -39.4% | |
Price / Book Value ratio | x | 1.9 | 6.8 | 27.8% | |
Dividend payout | % | -7.3 | 0 | - | |
Avg Mkt Cap | Rs m | 813 | 102 | 794.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 0 | 293.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 586 | 0 | - | |
Other income | Rs m | 0 | 2 | 2.5% | |
Total revenues | Rs m | 586 | 2 | 24,721.1% | |
Gross profit | Rs m | 27 | -1 | -2,012.9% | |
Depreciation | Rs m | 0 | 0 | 1,633.3% | |
Interest | Rs m | 48 | 0 | - | |
Profit before tax | Rs m | -22 | 1 | -2,110.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 0 | - | |
Profit after tax | Rs m | -22 | 1 | -2,122.5% | |
Gross profit margin | % | 4.5 | 0 | - | |
Effective tax rate | % | -0.5 | 0 | - | |
Net profit margin | % | -3.7 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 542 | 0 | 902,500.0% | |
Current liabilities | Rs m | 50 | 0 | 36,035.7% | |
Net working cap to sales | % | 83.8 | 0 | - | |
Current ratio | x | 10.7 | 0.4 | 2,504.5% | |
Inventory Days | Days | 749 | 0 | - | |
Debtors Days | Days | 3,041 | 0 | - | |
Net fixed assets | Rs m | 1,507 | 15 | 9,894.3% | |
Share capital | Rs m | 62 | 134 | 46.1% | |
"Free" reserves | Rs m | 371 | -119 | -311.0% | |
Net worth | Rs m | 433 | 15 | 2,856.5% | |
Long term debt | Rs m | 1,565 | 0 | - | |
Total assets | Rs m | 2,048 | 15 | 13,396.9% | |
Interest coverage | x | 0.5 | 0 | - | |
Debt to equity ratio | x | 3.6 | 0 | - | |
Sales to assets ratio | x | 0.3 | 0 | - | |
Return on assets | % | 1.3 | 6.7 | 19.1% | |
Return on equity | % | -5.0 | 6.7 | -74.5% | |
Return on capital | % | 1.3 | 6.7 | 19.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 26 | 1 | 2,385.0% | |
From Investments | Rs m | -160 | 13 | -1,211.7% | |
From Financial Activity | Rs m | 127 | -15 | -849.7% | |
Net Cashflow | Rs m | -8 | -1 | 1,196.9% |
Indian Promoters | % | 24.8 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 75.2 | 100.0 | 75.2% | |
Shareholders | 2,884 | 31,530 | 9.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ALFAVISION S With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA MSTC
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ALFAVISION S | WELCURE DRUG |
---|---|---|
1-Day | -0.28% | 0.00% |
1-Month | -4.59% | 25.19% |
1-Year | 16.46% | 20.54% |
3-Year CAGR | 54.52% | 34.09% |
5-Year CAGR | 33.80% | 60.31% |
* Compound Annual Growth Rate
Here are more details on the ALFAVISION S share price and the WELCURE DRUG share price.
Moving on to shareholding structures...
The promoters of ALFAVISION S hold a 24.8% stake in the company. In case of WELCURE DRUG the stake stands at 0.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALFAVISION S and the shareholding pattern of WELCURE DRUG.
Finally, a word on dividends...
In the most recent financial year, ALFAVISION S paid a dividend of Rs 0.1 per share. This amounted to a Dividend Payout ratio of -7.3%.
WELCURE DRUG paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of ALFAVISION S, and the dividend history of WELCURE DRUG.
For a sector overview, read our finance sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.